Health-Related Quality of Life in Patients with Untreated Higher-Risk Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Receiving Glasdegib plus Azacitidine

被引：0

作者：

Wang, Eunice ^{[1
]}

Bell, Timothy ^{[2
]}

Zeidan, Amer ^{[3
,4
]}

Bhattcharyya, Helen ^{[2
]}

Kudla, Arthur ^{[2
]}

Chan, Geoffrey ^{[2
]}

Sekeres, Mikkael ^{[5
]}

机构：

[1] Roswell Park Comprehens Canc Ctr, Buffalo, NY USA

[2] Pfizer Oncol, New York, NY USA

[3] Yale Univ, Sch Med, New Haven, CT USA

[4] Yale Canc Ctr, New Haven, CT USA

[5] Cleveland Clin, Leukemia Program, Cleveland, OH 44106 USA

来源：

关键词：

acute myeloid leukemia; glasdegib; azacitidine; health-related quality of life; AML;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AML-205

引用

页码：S191 / S191

页数：1